Indegene to raise $200 mn
‘Carlyle’s dedication to the healthcare sector with its deep pharmaceutical knowledge combined with Brighton Park’s technology industry experience makes the two companies the perfect partners to support the continued growth of our business,’ says CEO Manish Gupta.
Business for healthcare solutions Indegene Pvt. Ltd said it is raising $200 million to boost acquisitions and accelerate global expansion plans from US-based investment firms Carlyle Group and Brighton Park Capital.
The company was founded in the year 2018 by Anand Kiran, Gaurav Kapoor, Manish Gupta, Rajesh Nair, and Sanjay Parikh. By combining analytics, technology, processes, and medical knowledge seamlessly, Indegene Lifesystems helps global healthcare organizations solve complex challenges. When they want actual outcomes, clients prefer Indegene. Indegene Lifesystems helps customers drive sales and efficiency through giant strides in digital innovation, customer engagement, health reform, cost savings in healthcare, and progress in health outcomes.
Via a primary investment, Carlyle and Brighton Park Capital will select minority shares in Indegene along with a secondary sale by the Bengaluru-based company’s existing shareholders and early investors. There are regulatory approvals pending the deal.
We plan to step up the rate of acquisitions, mainly in the US and Europe. We are also looking for overseas expansion and will set up operations in Mexico. “Indegene, co-founder and CEO Manish Gupta, said in an interview that health tech has opportunities, and investors are taking note of that. “Carlyle’s dedication to the healthcare sector with its pharmaceutical expertise combined with Brighton Park’s technology industry experience makes the two companies the perfect partners to help the continued growth of our business.”
Investments in India by Carlyle include Piramal Pharma, Sequent Science Ltd, Medanta Medicity Hospital, and Metropolis Healthcare Diagnostic Center. As of September 2020, Carlyle has invested over $13 billion in equity in the healthcare sector globally.